Neuropsychological Functioning in Patients with Cushing’s Disease and Cushing’s Syndrome

Abstract

Purpose To present a systematic review of the presence and severity of neuropsychological impairment in the six main neuropsychological domains (attention, executive function, language, visuospatial processing, intelligence, and memory) in patients with Cushing’s disease (CD) and/or Cushing’s Syndrome (CS) at various stages of the illness. The work aims to identify neuropsychological leverage points for focused diagnosis and rehabilitation in CS/CD patients.

Methods A pubmed literature search was performed and augmented by searching the reference lists of review articles identified by this search strategy. After excluding irrelevant hits, we systematically extracted data from 27 studies for each main neuropsychological domain, differentiating between active disease, short- and long-term remission.

Results The literature gives evidence for neuropsychological impairment in all domains in Cushing patients with active disease. The most consistent impairments concerned memory and visuo-spatial processing, whereas the data are discordant for all other domains. Significant improvement of neuropsychological function – although not returning to normal in all domains – is shown in short-term and long-term remission of the disease. However, the published literature is thin, suffering from repetitive subsample analyses publishing, methodological concerns as lack of control for confounders such as depression.

Conclusions Memory is the most extensively investigated domain in CS/CD patients and impairment is most prominent in active disease. Patients should be counseled that neuropsychological function will improve with normalization of hypercortisolism and over time. More studies with more stringent methodological criteria, larger patient samples and controlling for confounders are required to enhance our understanding of neuropsychological function in patients with CS/CD.

Keywords

Cushing’s disease - Cushing’s syndrome - neuropsychological impairment - depression - rehabilitation

Publication History

Received: 25 March 2020
Received: 24 July 2020

Accepted: 19 August 2020

Article published online:
29 September 2020

• References

• 1 Kreitschmann-Andermahr I, Psaras T, Tsiogka M. et al. From first symptoms to final diagnosis of Cushing’s disease: Experiences of 176 patients. European Journal of Endocrinology 2015; 172: 285-289
• 2 Valassi E, Santos A, Yaneva M. et al. The European Registry on Cushing’s syndrome: 2-year experience. Baseline demographic and clinical characteristics. European Journal of Endocrinology 2011; 165: 383-392
• 3 Rubinstein G, Osswald A, Hoster E. et al. Time to diagnosis in Cushing’s syndrome: A meta-analysis based on 5367 patients. The Journal of Clinical Endocrinology and Metabolism 2019;
• 4 Papakokkinou E, Johansson B, Berglund P. et al. Mental Fatigue and Executive Dysfunction in Patients with Cushing’s Syndrome in Remission. Behavioural Neurology 2015; 173653
• 5 Nieman LK. Cushing’s syndrome: update on signs, symptoms and biochemical screening. European Journal of Endocrinology 2015; 173: M33-M38 DOI: 10.1530/eje-15-0464
• 6 Resmini E, Santos A, Webb SM. Cortisol Excess and the Brain. Frontiers of Hormone Research 2016; 46: 74-86 DOI: 10.1159/000443868
• 7 Tiemensma J, Kokshoorn NE, Biermasz NR. et al. Subtle cognitive impairments in patients with long-term cure of Cushing’s disease. The. Journal of Clinical Endocrinology and Metabolism 2010; 95: 2699-2714
• 8 Juruena MF. Early-life stress and HPA axis trigger recurrent adulthood depression. Epilepsy & Behavior 2014; 38: 148-159
• 9 De Kloet ER, Vreugdenhil E, Oitzl MS. et al. Brain corticosteroid receptor balance in health and disease. Endocrine Reviews 1998; 19: 269-301
• 10 De Kloet E, Meijer OC, de Nicola AF. et al. Importance of the brain corticosteroid receptor balance in metaplasticity, cognitive performance and neuro-inflammation. Frontiers in Neuroendocrinology 2018; 49: 124-145
• 11 Starkman MN, Gebarski SS, Berent S. et al. Hippocampal formation volume, memory dysfunction, and cortisol levels in patients with Cushing’s syndrome. Biological Psychiatry 1992; 32: 756-765
• 12 Bourdeau I, Bard C, Forget H. et al. Cognitive function and cerebral assessment in patients who have Cushing’s syndrome. Endocrinology and Metabolism Clinics of North America 2005; 34: 357-369
• 13 Brown ES. Effects of glucocorticoids on mood, memory, and the hippocampus. Treatment and preventive therapy. Ann NY Acad Sci 2009; 1179: 41-55 DOI: 10.1111/j.1749-6632.2009.04981.x
• 14 Andela CD, van Haalen FM, Ragnarsson O. et al. Mechanisms in Endocrinology: Cushing’s syndrome causes irreversible effects on the human brain: a systematic review of structural and functional magnetic resonance imaging studies. European Journal of Endocrinology 2015; 173: R1-R14
• 15 Culpepper L, Lam RW, McIntyre RS. Cognitive impairment in patients with depression: awareness, assessment, and management. J Clin Psychiatry 2017; 78: 1383-1394 DOI: 10.4088/JCP.tk16043ah5c
• 16 Moher D, Liberati A, Tetzlaff J. et al. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA Statement. PLOS Medicine 2009; 6: e1000097
• 17 Anderson JR. Cognitive Psychology and Its Implications. In: Worth Publishers; 2015
• 18 Hunt AR, Kingstone A. Covert and overt voluntary attention: Linked or independent?. Brain Res Cogn Brain Res 2003; 18: 102-105 DOI: 10.1016/j.cogbrainres.2003.08.006
• 19 Cosman J, Rizzo M. Attention. In: Arciniegas DB, Anderson CA, Filley CM, Eds, Behavioral Neurology & Neuropsychiatry. Cambridge: Cambridge University Press; 2013: 115-133
• 20 Cullum CM. Neuropsychological Assessment. In: Arciniegas DB, Anderson CA, Filley CM, Eds Behavioral Neurology & Neuropsychiatry. Cambridge: Cambridge University Press; 2013: 394-405
• 21 Martignoni E, Costa A, Sinforiani E. et al. The brain as a target for adrenocortical steroids: Cognitive implications. Psychoneuroendocrinology 1992; 17: 343-354
• 22 Mauri M, Sinforiani E, Bono G. et al. Memory impairment in Cushing’s disease. Acta Neurologica Scandinavica 1993; 87: 52-55
• 23 Forget H, Lacroix A, Somma M. et al. Cognitive decline in patients with Cushing’s syndrome. Journal of the International Neuropsychological Society : JINS 2000; 6: 20-29
• 24 Michaud K, Forget H, Cohen H. Chronic glucocorticoid hypersecretion in Cushing’s syndrome exacerbates cognitive aging. Brain and Cognition 2009; 71: 1-8 DOI: 10.1016/j.bandc.2009.02.013
• 25 Leon-Carrion J, Atutxa AM, Mangas MA. et al. A clinical profile of memory impairment in humans due to endogenous glucocorticoid excess. Clinical Endocrinology 2009; 70: 192-200
• 26 Starkman MN, Giordani B, Berent S. et al. Elevated cortisol levels in Cushing’s disease are associated with cognitive decrements. Psychosomatic Medicine 2001; 63: 985-993
• 27 Santos A, Resmini E, Gomez-Anson B. et al. Cardiovascular risk and white matter lesions after endocrine control of Cushing’s syndrome. European Journal of Endocrinology 2015; 173: 765-775
• 28 Santos A, Resmini E, Crespo I. et al. Small cerebellar cortex volume in patients with active Cushing’s syndrome. European Journal of Endocrinology 2014; 171: 461-469
• 29 Pires P, Santos A, Vives-Gilabert Y. et al. White matter involvement on DTI-MRI in Cushing’s syndrome relates to mood disturbances and processing speed: A case-control study. Pituitary 2017; 20: 340-348
• 30 Psaras T, Milian M, Hattermann V. et al. Predictive factors for neurocognitive function and Quality of Life after surgical treatment for Cushing’s disease and acromegaly. Journal of Endocrinological Investigation 2011; 34: e168-e177
• 31 Forget H, Lacroix A, Cohen H. Persistent cognitive impairment following surgical treatment of Cushing’s syndrome. Psychoneuroendocrinology 2002; 27: 367-383
• 32 Forget H, Lacroix A, Bourdeau I. et al. Long-term cognitive effects of glucocorticoid excess in Cushing’s syndrome. Psychoneuroendocrinology 2016; 65: 26-33
• 33 Ragnarsson O, Berglund P, Eder DN. et al. Long-term cognitive impairments and attentional deficits in patients with Cushing’s disease and cortisol-producing adrenal adenoma in remission. The. Journal of Clinical Endocrinology and Metabolism 2012; 97: E1640-E1648
• 34 Ragnarsson O, Glad CA, Berglund P. et al. Common genetic variants in the glucocorticoid receptor and the 11beta-hydroxysteroid dehydrogenase type 1 genes influence long-term cognitive impairments in patients with Cushing’s syndrome in remission. The. Journal of clinical endocrinology and metabolism 2014; 99: E1803-E1807
• 35 Ragnarsson O, Berglund P, Eder DN. et al. Neurodegenerative and inflammatory biomarkers in cerebrospinal fluid in patients with Cushing’s syndrome in remission. European journal of endocrinology 2013; 169: 211-215
• 36 Heald A, Parr C, Gibson C. et al. A cross-sectional study to investigate long-term cognitive function in people with treated pituitary Cushing’s disease. Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology and German Diabetes Association. 2006; 114: 490-497
• 37 Arciniegas DB. Executive Function. In: Arciniegas DB, Anderson CA, Filley CM, Eds, Behavioral Neurology & Neuropsychiatry. Cambridge: Cambridge University Press; 2013: 225-249
• 38 Funahashi S, Andreau JM. Prefrontal cortex and neural mechanisms of executive function. J Physiol Paris 2013; 107: 471-482 DOI: 10.1016/j.jphysparis.2013.05.001
• 39 Crespo I, Esther GM, Santos A. et al. Impaired decision-making and selective cortical frontal thinning in Cushing’s syndrome. Clinical Endocrinology 2014; 81: 826-833
• 40 Mendez MF. Language. In: Arciniegas DB, Anderson CA, Filley CM, Eds, Behavioral Neurology & Neuropsychiatry. Cambridge: Cambridge University Press; 2013: 174-183
• 41 Hook JN, Giordani B, Schteingart DE. et al. Patterns of cognitive change over time and relationship to age following successful treatment of Cushing’s disease. Journal of the International Neuropsychological Society : JINS 2007; 13: 21-29
• 42 Merims D, Freedman M. Visuospatial Function. In: Arciniegas DB, Anderson CA, Filley CM, Eds, Behavioral Neurology & Neuropsychiatry. Cambridge: Cambridge University Press; 2013: 214-224
• 43 DeBrigard F, Giovanello KS, Kaufer DI. Memory. In: Arciniegas DB, Anderson CA, Filley CM, Eds, Behavioral Neurology & Neuropsychiatry. Cambridge: Cambridge University Press; 2013: 161-173
• 44 Grillon C, Smith K, Haynos A. et al. Deficits in hippocampus-mediated Pavlovian conditioning in endogenous hypercortisolism. Biological Psychiatry 2004; 56: 837-843
• 45 Maheu FS, Mazzone L, Merke DP. et al. Altered amygdala and hippocampus function in adolescents with hypercortisolemia: A functional magnetic resonance imaging study of Cushing syndrome. Development and Psychopathology 2008; 20: 1177-1189
• 46 Resmini E, Santos A, Gomez-Anson B. et al. Verbal and visual memory performance and hippocampal volumes, measured by 3-Tesla magnetic resonance imaging, in patients with Cushing’s syndrome. The. Journal of Clinical Endocrinology and Metabolism 2012; 97: 663-671
• 47 Ragnarsson O, Stomby A, Dahlqvist P. et al. Decreased prefrontal functional brain response during memory testing in women with Cushing’s syndrome in remission. Psychoneuroendocrinology 2017; 82: 117-125
• 48 Sternberg RJ. Intelligence. Dialogues in Clinical Neuroscience 2012; 14: 19-27
• 49 Wechsler D. The measurement of adult intelligence. 1939:
• 50 Dorn LD, Cerrone P. Cognitive function in patients with Cushing syndrome: A longitudinal perspective. Clinical Nursing Research 2000; 9: 420-440 DOI: 10.1177/10547730022158672
• 51 Merke DP, Giedd JN, Keil MF. et al. Children experience cognitive decline despite reversal of brain atrophy one year after resolution of Cushing syndrome. J Clin Endocrinol Metab 2005; 90: 2531-2536
• 52 Scoville WB, Milner B. Loss of recent memory after bilateral hippocampal lesions. Journal of neurology, neurosurgery, and psychiatry 1957; 20: 11-21 DOI: 10.1136/jnnp.20.1.11
• 53 Moser EI, Moser MB, McNaughton BL. Spatial representation in the hippocampal formation: A history. Nat Neurosci 2017; 20: 1448-1464 DOI: 10.1038/nn.4653
• 54 De Kloet E. M J, F H Stress and the brain: From adaptation to disease. Nat Rev Neurosci 2005; 6: 463-475
• 55 Joels M, Karst H, Sarabdjitsingh RA. The stressed brain of humans and rodents. Acta Physiol (Oxf) 2018; 223: e13066 DOI: 10.1111/apha.13066
• 56 Sapolsky RM. Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders. Arch Gen Psychiatry 2000; 57: 925-935 DOI: 10.1001/archpsyc.57.10.925
• 57 Starkman MN, Giordani B, Gebarski SS. et al. Improvement in learning associated with increase in hippocampal formation volume. Biological psychiatry 2003; 53: 233-238
• 58 Toffanin T, Nifosi F, Follador H. et al. Volumetric MRI analysis of hippocampal subregions in Cushing’s disease: A model for glucocorticoid neural modulation. Eur Psychiatry 2011; 26: 64-67
• 59 Wechsler D, De Lemos MM. Wechsler adult intelligence scale-revised. Harcourt Brace Jovanovich; 1981
• 60 Rock PL, Roiser JP, Riedel WJ. et al. Cognitive impairment in depression: a systematic review and meta-analysis. Psychol Med 2014; 44: 2029-2040
• 61 Tetzner J, Schuth M. Anxiety in late adulthood: Associations with gender, education, and physical and cognitive functioning. Psychology and Aging 2016; 31: 532